Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2025)

Zymeworks' Other Non-Current Liabilities history spans 3 years, with the latest figure at $1.9 million for Q3 2023.

  • For Q3 2023, Other Non-Current Liabilities rose 123.86% year-over-year to $1.9 million; the TTM value through Sep 2023 reached $1.9 million, up 123.86%, while the annual FY2022 figure was $3.1 million, 12.85% up from the prior year.
  • Other Non-Current Liabilities for Q3 2023 was $1.9 million at Zymeworks, down from $3.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.6 million in Q2 2023 and bottomed at $830000.0 in Q3 2022.
  • The 3-year median for Other Non-Current Liabilities is $2.3 million (2021), against an average of $2.3 million.
  • The largest annual shift saw Other Non-Current Liabilities rose 12.85% in 2022 before it soared 123.86% in 2023.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $2.7 million in 2021, then increased by 12.85% to $3.1 million in 2022, then crashed by 40.08% to $1.9 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Other Non-Current Liabilities are $1.9 million (Q3 2023), $3.6 million (Q2 2023), and $1.5 million (Q1 2023).